Seattle biotech Kineta teams up with Genentech to create chronic pain medicine
Seattle Times Seattle biotech Kineta will partner with big biotech company Genentech to make and sell a drug used to treat chronic pain, in a deal that could be worth more than $359 million for the Seattle company. Kineta announced Monday it made a deal with San … |
Source:: Seattle News By Google News